DOI:
10.1055/s-00000153
Zeitschrift für Komplementärmedizin
LinksClose Window
References
Henderson ST, Vogel JL. et al.
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial..
Nutr Metab (Lond.) 2009;
6: 31 doi: 10.1186/1743-7075-6-31
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.